Related Experiment Video

Updated: May 29, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

The role of mitogen- and stress-activated protein kinase pathways in melanoma

Pablo Lopez-Bergami1

  • 1Instituto de Medicina y Biología Experimental, CONICET, Buenos Aires, Argentina. pablobergami@gmail.com

Pigment Cell & Melanoma Research
|September 15, 2011
PubMed

Insights

This review details the critical roles of mitogen-activated protein kinase (MAPK) pathways in melanoma development and resistance. Understanding these pathways is key to overcoming therapeutic challenges in melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma development and progression are driven by molecular signaling events.
  • Key oncogenes activate the RAF/MEK/ERK mitogen-activated protein kinase (MAPK) pathway.
  • The roles of c-Jun N-terminal kinase (JNK) and p38 MAPK pathways in melanoma require further clarification.

Purpose of the Study:

  • To review the current understanding of the three main MAPK pathways (ERK, JNK, and p38) in melanoma biology.
  • To explore the impact of these pathways on melanoma development and progression.
  • To discuss the implications for melanoma therapy and resistance mechanisms.

Main Methods:

  • Literature review of recent discoveries in melanoma molecular signaling.
  • Analysis of the roles of ERK, JNK, and p38 MAPK pathways.
  • Examination of BRAF inhibitors and acquired resistance mechanisms.

Main Results:

  • Mitogen-activated protein kinase (MAPK) pathways, particularly ERK, are crucial in melanoma.
  • While BRAF inhibitors show promise, acquired resistance is a significant challenge.
  • Interconnections between MAPK pathways and other signaling networks are vital for melanoma progression.

Conclusions:

  • A comprehensive understanding of MAPK pathway functions and their interconnections is essential for advancing melanoma therapy.
  • Targeting MAPK pathways and overcoming resistance mechanisms are critical future directions.
  • Further research into the precise roles of JNK and p38 pathways may reveal new therapeutic strategies.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...